Expert Rev Anti Infect Ther. 2011;9(11):993-1000. † Endotracheally instilled (ET) therapy alone vs intravenous therapy alone. ‡ ET sisomicin vs ET placebo. § Aerosolized tobramycin vs no ...

For example, toxicology studies with inhaled ... thereby preventing progression of lung disease. Some aerosolized antibiotics have been shown to provide clinical efficacy, due to high sputum ...

Aerosolized antibiotics have a central role in treating pulmonary infections in these patients. Until this year, the only FDA-approved inhaled option was tobramycin for inhalation solution (Tobi ...

Taking antibiotics for a viral infection like a cold or the flu (for which antibiotics are ineffective) is an example of misuse of antibiotics. Another example is giving antibiotics to healthy animals ...

Resistance to antibiotics has led to one million worldwide deaths each year since 1990, for a total of 36 million. It is expected to cause more than 39 million more fatalities by 2050 — three ...

Forty or fifty years ago, thanks to antibiotics, scientists thought medicine had all but eradicated infectious agents as a major health threat. Instead, the past two decades have seen an alarming ...

Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...

Evolutionary biologist Tiffany Taylor explores the work being done to resensitize antibiotic-resistant bacteria ... its root genetic cause. For example, research from Despoina Mavridou, an ...

It is the latest example of how the tools of artificial intelligence can be a revolutionary force in science and medicine. Antibiotics kill bacteria. However, there has been a lack of new drugs ...

Antibiotic Overuse in Nursing Homes Could Foster 'Superbugs' By Dennis Thompson HealthDay Reporter FRIDAY, Aug. 30, 2024 (HealthDay News) -- Senior residential homes are breeding grounds for ...

Such an environment may foster innovation." In that conflict, de la Fuente's lab sees potential for new antibiotics, which ...